There are no reports of hepatic impairment in patients with autosomal-dominant TANC2 mutation thus far (Guo et al., 2019), although at least one patient in this study exhibited obesity with fatty liver. This evidence concerns the gene TANC2 and obesity due to melanocortin 4 receptor deficiency.